ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,346Medicare Part D Prescriptions Filled, Including Refills

Rank: 104 out of 780

$827K Total Retail Price of All Prescriptions

Rank: 117 out of 780

679 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 679 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 13,853 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
PRAVASTATIN SODIUM 691 603 1 9
HYDRALAZINE HCL 691 551 1 54
MELOXICAM 609 521 3 16
LEVOTHYROXINE SODIUM 573 512 4 5
AMLODIPINE BESYLATE 568 456 5 4
METFORMIN HCL 458 370 6 8
OMEPRAZOLE 435 321 7 3
LISINOPRIL 394 305 8 6
SIMVASTATIN 390 336 9 2
FUROSEMIDE 380 299 10 7
HYDROCODONE-ACETAMINOPHEN 345 220 S3 11 1
METOPROLOL TARTRATE 318 291 12 19
PANTOPRAZOLE SODIUM 269 201 13 25
TRAMADOL HCL 260 176 14 15
ATORVASTATIN CALCIUM 254 204 15 12
TAMSULOSIN HCL 229 194 16 36
FLUTICASONE PROPIONATE 227 155 17 41
HYDROCHLOROTHIAZIDE 219 185 18 10
CITALOPRAM HBR 211 169 19 23
CYCLOBENZAPRINE HCL 206 139 R 20 42
GLIMEPIRIDE 202 166 21 30
NEXIUM 195 158 22 22
KLOR-CON M20 195 185 22 57
CARVEDILOL 194 125 24 14
TRIAMTERENE-HCTZ 174 160 25 37
COLCRYS 168 111 26 131
CRESTOR 165 132 27 32
LISINOPRIL-HYDROCHLOROTHIAZIDE 155 127 28 26
METOPROLOL SUCCINATE 145 122 29 20
ALLOPURINOL 141 123 30 29
SINGULAIR 138 94 31 73
POTASSIUM CHLORIDE 138 77 31 11
ZOLPIDEM TARTRATE 138 96 31 17
DOXYCYCLINE HYCLATE 136 95 34 103
CLOPIDOGREL 135 106 35 34
AZITHROMYCIN 130 85 36 38
ZETIA 123 105 37 94
CLONIDINE HCL 119 75 38 28
KLOR-CON 10 117 95 39 90
DIOVAN 113 100 40 55
ESCITALOPRAM OXALATE 103 78 41 61
DIGOXIN 101 89 42 56
AMLODIPINE BESYLATE-BENAZEPRIL 98 87 43 50
PLAVIX 97 78 44 45
METHYLPREDNISOLONE 96 79 45 92
GABAPENTIN 96 55 45 13
MECLIZINE HCL 95 78 47 83
JANUVIA 95 92 47 85
DONEPEZIL HCL 93 93 49 31
GLYBURIDE-METFORMIN HCL 91 79 R 50 108
DIOVAN HCT 90 84 51 75
WARFARIN SODIUM 88 69 52 24
MONTELUKAST SODIUM 88 53 52 120
CIPROFLOXACIN HCL 85 75 54 49
VYTORIN 85 61 54 206
EVISTA 78 74 56 151
METFORMIN HCL ER 78 70 56 43
LOSARTAN POTASSIUM 77 54 58 18
NAMENDA 73 61 59 46
DILTIAZEM ER 72 72 60 134
LYRICA 71 56 61 52
BENAZEPRIL HCL 71 70 61 59
ISOSORBIDE MONONITRATE ER 70 60 63 60
LOVASTATIN 69 60 64 47
SPIRIVA 69 65 64 72
ATENOLOL 67 64 66 21
EXFORGE 67 43 66 196
TRIAMTERENE-HYDROCHLOROTHIAZID 66 60 68 162
MEGESTROL ACETATE 65 62 R 69 161
PREMARIN 64 39 R 70 110
HUMULIN 70-30 61 46 71 106
GLIPIZIDE 61 52 71 74
LOSARTAN-HYDROCHLOROTHIAZIDE 60 45 73 33
NIASPAN 59 58 74 167
PROMETHAZINE HCL 57 33 R 75 66
CARISOPRODOL 57 14 R 75 67
CYMBALTA 57 51 75 51
BISOPROLOL-HYDROCHLOROTHIAZIDE 56 56 78 95
ALENDRONATE SODIUM 55 55 79 44
INSULIN SYRINGE 54 49 80 80
QUINAPRIL HCL 54 22 80 113
OXYBUTYNIN CHLORIDE 52 49 82 148
NIFEDIPINE ER 51 51 83 115
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.